The Molecular Biology of Cervical Cancer

REFERENCES

• American Cancer Society. Cancer Facts and Figures 1997. American Cancer Society, Washington, DC 1997
   Google Scholar
• Bishop J. M. Molecular Themes in Oncogenesis. Cell 1991; 64: 235–248
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. Papillomavirus Infections—a Major Cause of Human Cancers. Biochem. Biophys. Acta 1996; 1288: 55–78
   PubMed Web of Science ®Google Scholar
• Park T. W., Fujiwara H., Wright T. C. Molecular Biology of Cervical Cancer and Its Precursors. Cancer Suppl. 1995; 76: 1902–1913
   PubMed Web of Science ®Google Scholar
• Felix J. F., Wright T. C. Analysis of Lower Genital Tract Lesions Clinically Suspicious for Condylomata Using In Situ Hybridization and the Polymerase Chain Reaction for the Detection of Human Papillomavirus. Arch. Pathol. Lab. Med. 1994; 118: 39–43
   PubMed Web of Science ®Google Scholar
• Bergeron C., Barrasso R., Beaudenon S., Flamant P., Croissant O., Orth G. Human Papillomaviruses Associated with Cervical Intraepithelial Neoplasia: Great Diversity and Distinct Distribution in Low-and High-Grade Lesions. Am. J. Surg. Pathol. 1992; 16: 641–740
   PubMed Web of Science ®Google Scholar
• Genest D. R., Stein L., Cibas E., Sheets E., Zitz J. C., Crum C. P. A Binary (Bethesda) System for Classifying Cervical Cancer Precursors: Criteria, Reproducibility, and Viral Correlates. Hum. Pathol. 1993; 24: 730–736
   PubMed Web of Science ®Google Scholar
• Lorincz A. T., Reid R., Jenson A. B., Greenberg M. D., Lancaster W., Kurman R. J. Human Papillomavirus Infection of the Cervix: Relative Risk Associations of 15 Common Anogenital Types. Obstet. Gynecol. 1992; 79: 328–337
   PubMed Web of Science ®Google Scholar
• Turek L. P. The Structure, Function and Regulation of Papillomaviral Genes in Infection and Cancer. Adv. Viral Res. 1994; 44: 305–356
   PubMed Web of Science ®Google Scholar
• Barbosa M. S., Lowry D. R., Schiller J. T. Papillomavirus Polypeptides E6 and E7 Are Zinc-Binding Proteins. J. Virol. 1989; 63: 1404–1407
   PubMed Web of Science ®Google Scholar
• Rodrigues N. R., Rowan A., Smith M. E., Kerr I. B., Bodmer W. F., Gannon J. V., Lane D. P. p53 Mutations in Colorectal Cancer. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 7555–7559
   PubMed Web of Science ®Google Scholar
• Bartek J., Iggo R., Gannon J., Lane D. P. Genetic and Immunochemical Analysis of Mutant p53 in Human Breast Cancer Cell Lines. Oncogene 1990; 5: 893–899
   PubMed Web of Science ®Google Scholar
• Takahashi T., Suzuki H., Sekido Y., Ariyoshi Y., Ueda R. The p53 Gene Is Very Frequently Mutated in Small-Cell Lung Cancer with a Distinct Nucleotide Substitution Pattern. Oncogene 1991; 6(10)1775–1778
   PubMed Web of Science ®Google Scholar
• Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 Mutations in Human Cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Levine A. J., Momand J., Finlay C. A. The p53 Tumor Suppressor Gene. Nature 1991; 351: 453–465
   PubMed Web of Science ®Google Scholar
• El-Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y. WAF1/CIP1 Is Induced in p53-Mediated G1 Arrest and Apoptosis. Cancer Res. 1994; 54: 1169–1174
   PubMed Web of Science ®Google Scholar
• Selvakumaran M., Lin H. K., Miyashita T., Wang H. G., Krajewski S., Reed J. C., Hoffman B., Liebermann D. Immediate Early Upregulation of bax Expression by p53 But Not by TGFβ1: A Paradigm for Distinct Apoptotic Pathways. Oncogene 1994; 9: 1791–1798
   PubMed Web of Science ®Google Scholar
• Werness B. A., Levine A. J., Howley P. M. Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53. Science 1990; 248: 76–79
   PubMed Web of Science ®Google Scholar
• Crook T., Tidy J. A., Vousden K. H. Degradation of p53 Can Be Targeted by HPV E6 Sequences Distinct from Those Required for p53 Binding and Transactivation. Cell 1991; 67: 547–556
   PubMed Web of Science ®Google Scholar
• Lechner M. S., Laimins L. A. Inhibition of p53 DNA Binding by Human Papillomavirus E6 Proteins. J. Virol. 1994; 68: 4262–4273
   PubMed Web of Science ®Google Scholar
• Kim J. W., Cho Y. H., Lee C. G., Kim J. H., Kim H. K., Kim E. J., Han K. T., Namkoong S. E. Human Papillomavirus Infection and TP53 Gene Mutation in Primary Cervical Carcinoma. Acta Oncol. 1997; 36: 295–300
   PubMed Web of Science ®Google Scholar
• Crook T., Wrede D., Tidy J. A., Mason W. P., Evans D. J., Vousden K. H. Clonal p53 Mutation in Primary Cervical Cancer: Association with Human-Papillomavirus-Negative Tumors. Lancet 1992; 339: 1070–1073
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Kinzler K. The Multistep Nature of Cancer. Trends Genet. 1993; 9: 138–141
   PubMed Web of Science ®Google Scholar
• Akiyama T., Ohuchi T., Sumida S., Matsumoto K., Toyoshima K. Phosphorylation of the Retinoblastoma Protein by cdk2. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 7900–7904
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. The Retinoblastoma Protein and Cell Cycle Control. Cell 1995; 81: 323–330
   PubMed Web of Science ®Google Scholar
• Jones D. L., Alani R. M., Munger K. The Human Papillomavirus E7 Oncoprotein Can Uncouple Cellular Differentiation and Proliferation in Human Keratinocytes by Abrogating p21Cip1-Mediated Inhibition of cdk-2. Genes Dev. 1997; 11: 2101–2111
   PubMed Web of Science ®Google Scholar
• Zerfass-Thome K., Zwerschke W., Mannhardt B., Tindle R., Botz J. W., Janson-Durr P. Inactivation of the cdk Inhibitor p27KIP1 by the Human Papillomavirus Type 16 E7 Oncoprotein. Oncogene 1996; 13: 2323–2330
   PubMed Web of Science ®Google Scholar
• Momand J., Zambetti G. P., Olson D. C., George D., Levine A. J. The mdm-2 Oncogene Product Forms a Complex with the p53 Protein and Inhibits p53-Mediated Transactivation. Cell 1992; 69: 1237–1245
   PubMed Web of Science ®Google Scholar
• Xiao Z. X., Chen J., Levine A. J., Modjtahedi N., Xing J., Sellers W. R., Livingston D. M. Interaction Between the Retinoblastoma Protein and the Oncoprotein MDM2. Nature 1995; 375: 694–698
   PubMed Web of Science ®Google Scholar
• Skomedal H., Kristensen G. B., Lie A. K., Holm R. Aberrant Expression of the Cell Cycle Associated Proteins TP53, MDM2, p21, p27, cdk4, Cyclin D1, RB and EGFR in Cervical Carcinomas. Gynecol. Oncol. 1999; 73: 223–228
   PubMed Web of Science ®Google Scholar
• Larson A. A., Kern S., Curtiss S., Gordon R., Cavenee W. K., Hampton G. M. High Resolution Analysis of Chromosome 3p Alterations in Cervical Cancer. Cancer Res. 1997; 57: 4082–4090
   PubMed Web of Science ®Google Scholar
• Chu T. Y., Shen C. Y., Chiou Y. S., Lu J. J., Perng C. L., Yu M. S., Liu H. S. HPV-Associated Cervical Cancers Show Frequent Allelic Loss at 3p14 But No Apparent Aberration of FHIT mRNA. Int. J. Cancer 1998; 75: 199–204
   PubMed Web of Science ®Google Scholar
• Wistuba I. I., Montellano F. D., Milchgrub S., Virmani A. K., Behrens C., Chen H., Ahmadian M., Nowak J. A., Muller C., Minna J. D., Gazdar A. F. Deletions of Chromosome 3p Are Frequent and Early Events in the Pathogenesis of Uterine Cervical Carcinoma. Cancer Res. 1997; 57: 3154–3158
   PubMed Web of Science ®Google Scholar
• Rader J. S., Gerhard D. S., O'Sullivan M. J., Li Y., Li L., Liapis H., Huettner P. C. Cervical Intraepithelial Neoplasia III Shows Frequent Allelic Loss in 3p and 6p. Genes Chrom. Cancer 1998; 22: 57–65
   PubMed Web of Science ®Google Scholar
• Ohta M., Inoue H., Cotticelli M. G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal-Carcinoma-Associated t(3; 8) Breakpoint, Is Abnormal in Digestive-Tract Cancers. Cell 1996; 84: 587–597
   PubMed Web of Science ®Google Scholar
• Jou T. S., Stewart D. B., Stappert J., Nelson W. J., Marrs J. A. Genetic and Biochemical Dissection of Protein Linkages in the Cadherin-Catenin Complex. Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 5067–5071
   PubMed Web of Science ®Google Scholar
• Kersemaekers A. M.F., Hermans J., Fleuren G. J., van de Vijver M. J. Loss of Heterozygosity for Defined Regions on Chromosomes 3, 11 and 17 in Carcinomas of the Uterine Cervix. Br. J. Cancer 1998; 77: 192–200
   PubMed Web of Science ®Google Scholar
• Vastrick I., Makela T. P., Koskinen P. J., Klefstrom J., Alitalo K. Myc Protein: Partners and Antagonists. Crit. Rev. Oncol. 1994; 5: 59–68
   Google Scholar
• Evan G., Harrington E., Fanidi A., Land H., Amati B., Bennett M. Integrated Control of Cell Proliferation and Cell Death by the c-myc Oncogene. Philos. Trans. R. Soc. Lond. Biol. Sci. 1994; 345: 269–275
   PubMed Web of Science ®Google Scholar
• Riou G., Barrois M., Le M. G., George M., Le Doussal V., Haie C. C-myc proto-Oncogene Expression and Prognosis in Early Carcinoma of the Cervix. Lancet 1987; 1(8536)761–763
   PubMed Web of Science ®Google Scholar
• Bourhis J., Le M. G., Barrois M., Gerbaulet A., Jeannel D., Duvillard P., Le Doussal V., Chassagne D., Riou G. Prognostic Value of c-myc Proto-Oncogene Overexpression in Early Invasive Carcinoma of the Cervix. J. Clin. Oncol. 1990; 8: 1789–1796
   PubMed Web of Science ®Google Scholar
• Baker V. V., Hatch K. D., Shingleton H. M. Amplification of the c-myc Proto-Oncogene in Cervical Carcinoma. J. Surg. Oncol. 1988; 39: 225–228
   PubMed Web of Science ®Google Scholar
• Kiaris H., Spandidos D. A. Mutations of ras Genes in Human Tumours (Review). Int. J. Oncol. 1995; 7: 413–421
   PubMed Web of Science ®Google Scholar
• Teneriello M. G., Ebina M., Linnoila R. I., Henry M., Nash J. D., Park R. C., Birrer M. J. p53 and K-ras Gene Mutations in Epithelial Ovarian Neoplasms. Cancer Res. 1993; 53: 3103–3108
   PubMed Web of Science ®Google Scholar
• The Super-Family of ras Related Genes, D. A. Spandidos. Plenum Press, New York 1991; 11–338
   Google Scholar
• Dokianakis D. N., Sourvinos G., Sakkas S., Athanasiadou E., Spandidos D. A. Detection of HPV and ras Gene Mutations in Cervical Smears from Female Genital Lesions. Oncol. Rep. 1998; 5: 1195–1198
   PubMed Web of Science ®Google Scholar
• Garzetti G. G., Ciavattini A., Lucarini G., Goteri G., Nictolis M. D., Romanini C., Biagini G. ras p21 Immunostaining in Early Stage Squamous Cervical Carcinoma: Relationship with Lymph Node Involvement and 72 kDa-Metalloproteinase Index. Anticancer Res. 1998; 18: 609–613
   PubMed Web of Science ®Google Scholar
• Lakshmi S., Balaraman Nair M., Jayaprakash P. G., Rajalekshmy T. N., Nair M. K., Pillai M. R. c-erbB-2 Oncoprotein and Epidermal Growth Factor Receptor in Cervical Lesions. Pathobiology 1997; 65: 163–168
   PubMed Web of Science ®Google Scholar
• Kay E. W., Walsh C. J.B., Cassidy M., Curran B., Leader M. c-erbB-2 Immunostaining: Problems with Interpretation. J. Clin. Pathol. 1994; 47: 816–822
   PubMed Web of Science ®Google Scholar
• Berchuck A., Rodriguez G., Kamel A., Soper J. T., Clarke-Pearson D. L., Bast R. C. Expression of the Epidermal Growth Factor Receptor and HER-2/neu in Normal and Neoplastic Cervix, Vulva and Vagina. Obstet. Gynecol. 1990; 76: 381–387
   PubMed Web of Science ®Google Scholar
• Zhang H., Hannon G. J., Beach D. p21-Containing Cyclin Kinases Exist in Both Active and Non-active States. Genes Dev. 1994; 8: 1750–1758
   PubMed Web of Science ®Google Scholar
• Kim J. W., Kim H. S., Kim I. K., Kim M. R., Cho E. Y., Kim H. K., Lee J. M., Namkoong S. E. Transforming Growth Factor-β1 Induces Apoptosis Through Down-Regulation of c-myc Gene and Over Expression of p27Kip1 Protein in Cervical Carcinoma. Gynecol. Oncol. 1998; 69: 230–236
   PubMed Web of Science ®Google Scholar
• Tusjimoto Y., Finger L. R., Yunis J., Nowell P. C., Croce C. M. Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation. Science 1984; 226: 1097–1099
   PubMed Web of Science ®Google Scholar
• Krajewski S., Tanaka A., Takayama S., Schibler M. J., Fenton W., Reed J. C. Investigation of the Subcellular Distribution of the bcl-2 Oncoprotein: Residence in the Nuclear Envelope, Endoplasmic Reticulum, and Outer Mitochondrial Membranes. Cancer Res. 1993; 53: 4701–4714
   PubMed Web of Science ®Google Scholar
• Tjalma W., Weyler J., Goovaerts G., De Pooter C., Van Marck E., van Dam P. Prognostic Value of bcl-2 Expression in Patients with Operable Carcinoma of the Cervix. J. Clin. Pathol. 1997; 50: 33–36
   PubMed Web of Science ®Google Scholar
• Tjalma W., DeCuyper E., Weyler J., Van Marck E., De Pooter C., Albertyn G., van Dam P. Expression of bcl-2 in Invasive and In Situ Carcinoma of the Uterine Cervix. Am. J. Obstet. Gynecol. 1998; 178: 113–117
   PubMed Web of Science ®Google Scholar
• Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association Between Tumor Hypoxia and Malignant Progression in Advanced Cancer of the Uterine Cervix. Cancer Res. 1996; 56: 4509–4515
   PubMed Web of Science ®Google Scholar
• Siracka E., Siracky J., Pappova N. Vascularization and Radiocurability in Cancer of the Uterine Cervix. A Retrospective Study. Neoplasma 1994; 29: 183–188
   Google Scholar
• Kohno Y., Iwanari O., Kitao M. Importance of Histological Vascular Density in Cervical Cancer Treated with Intra-Arterial Chemotherapy. Cancer 1993; 72: 2394–2400
   PubMed Web of Science ®Google Scholar
• Bossi P., Viale G., Lee A. K., Alfano R., Coggi G., Bosari S. Angiogenesis in Colorectal Tumors: Microvessel Quantitation in Adenomas and Carcinomas with Clinicopathological Correlations. Cancer Res. 1995; 55: 5049–5053
   PubMed Web of Science ®Google Scholar
• Rutgers J. L., Mattox T. F., Vargas M. P. Angiogenesis in Uterine Cervical Squamous Cell Carcinoma. Int. J. Gynecol. Pathol. 1995; 14: 114–118
   PubMed Web of Science ®Google Scholar
• Raleigh J. A., Calkins-Adams D. P., Rinker L. H., Ballenger C. A., Weissler M. C., Fowler W. C., Novotny D. B., Varia M. A. Hypoxia and Vascular Endothelial Growth Factor Expression in Human Squamous Cell Carcinomas Using Pimonidazole as a Hypoxia Marker. Cancer Res. 1998; 58: 3765–3768
   PubMed Web of Science ®Google Scholar
• Senger D. R., Brown L. F., Claffey K. P., Dvorak H. F. Vascular Permeability Factor, Tumor Angiogenesis and Stroma Generation. Invasion Metastasis 1994; 14: 385–394
   PubMedGoogle Scholar
• Odunsi K. O., Ganesan T. S. The Roles of Human Major Histocompatibility Complex and Human Papillomavirus Infection in Cervical Intraepithelial Neoplasia and Cervical Cancer. Clin. Oncol. 1997; 9: 4–13
   Google Scholar
• Tsukui T., Hildesheim A., Schiffman M. H., Lucci J., Contois D., Lawler P., Rush B. B., Lorincz A. T., Corrigan A., Burk R. D., Qu W., Marshall M. A., Mann D., Carrington M., Clerici M., Shearer G. M., Carbone D. P., Scott D. R., Houghten R. A., Berzofsky J. A. IL-2 Production by Peripheral Lymphocytes in Response to Human Papillomavirus-Derived Peptides: Correlation with Cervical Pathology. Cancer Res. 1996; 56: 3967–3974
   PubMed Web of Science ®Google Scholar
• Al-Saleh W., Gianinni S. L., Jacobs N., Moutschen M., Doyen J., Boniver J., Delvenne P. Correlation of Thelper Secretory Differentiation and Types of Antigen-Presenting Cells in Squamous Intraepithelial Lesions of the Uterine Cervix. J. Pathol. 1998; 184: 283–290
   PubMed Web of Science ®Google Scholar
• Hildesheim A., Schiffman M. H., Tsukui T., Swanson C. A., Lucci J., Scott D. R., Glass A. G., Rush B. B., Lorincz A. T., Corrigan A., Burk R. D., Helgesen K., Houghten R. A., Sherman M. E., Kurman R. J., Berzofsky J. A., Kramer T. R. Immune Activation in Cervical Neoplasia: Cross Sectional Association Between Plasma Soluble Interleukin 2 Receptor Levels and Disease. Cancer Epidemiol. Biomarkers Prev. 1997; 6: 807–813
   PubMed Web of Science ®Google Scholar
• Gianinni S. L., Al-Saleh W., Piron H., Jacobs N., Doyen J., Boniver J., Delvenne P. Cytokine Expression in Squamous Intraepithelial Lesions of the Uterine Cervix: Implications for the Generation of Local Immunosuppression. Clin. Exp. Immunol. 1998; 113: 183–189
   PubMed Web of Science ®Google Scholar
• Borysiewicz L. K., Fiander A., Nimako M., Man S., Wilkinson G. W., Westmoreland D., Evans A. S., Adams M., Stacey S. N., Boursnell M. E., Rutherford E., Hickling J. K., Inglis S. C. A Recombinant Vaccinia Virus Encoding Human Papillomavirus Types 16 and 18, E6 and E7 Proteins as Immunotherapy for Cervical Cancer. Lancet 1996; 347: 1523–1527
   PubMed Web of Science ®Google Scholar
• Hamada K., Zhang W. W., Alemany R., Wolf J., Roth J. A., Mitchell M. F. Growth Inhibition of Human Cervical Cancer Cells with the Recombinant Adenovirus p53 In Vitro. Gynecol. Oncol. 1996; 60: 373–379
   PubMed Web of Science ®Google Scholar